Universal Health Realty Income Trust (UHT) has just wrapped up FY 2025 with Q4 revenue of US$23.3 million and basic EPS of US$0.31, alongside Funds From Operations of a loss of US$35.9 million that will likely catch investors’ attention. The trust has seen quarterly revenue move from US$24.8 million in Q3 2024 to between US$24.0 million and US$25.7 million through 2025, while basic EPS ranged from US$0.29 to US$0.35 across those same quarters. This sets up a picture where headline profitability metrics, including a 17.8% net margin over the last 12 months, sit against a well flagged earnings decline and a relatively high dividend yield. Overall, the latest numbers point to margins that have compressed versus the prior year, which puts extra focus on how sustainable the current income profile really is for shareholders.
See our full analysis for Universal Health Realty Income Trust.With the raw results on the table, the next step is to see how these figures line up with the stories investors usually tell about UHT, and where the earnings and margin trends either support or challenge those narratives.
Curious how numbers become stories that shape markets? Explore Community Narratives
Want a clearer sense of how other investors interpret this mix of premium P/E, high yield, and softer margins for UHT? 📊 Read the what the Community is saying about Universal Health Realty Income Trust.
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Universal Health Realty Income Trust's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
Reading all this, you can see why opinions on UHT are split. It makes sense to look through the numbers yourself and decide how you feel about the balance between income, valuation, and balance sheet risks, then check out 2 key rewards and 2 important warning signs to see the full list of issues and potential positives investors are focusing on today.
UHT is facing weaker earnings trends, margin pressure, slower 3% revenue growth versus the wider market, and interest coverage concerns despite a relatively high dividend yield.
If those mix of pressures makes you want more cushion in your portfolio, check out our 80 resilient stocks with low risk scores to quickly spot companies with more resilient profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com